These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17131324)

  • 21. Postmenopausal hormone therapy and mammographic breast density.
    Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
    Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic density changes during different postmenopausal hormone replacement therapies.
    Sendağ F; Coşan Terek M; Ozşener S; Oztekin K; Bilgin O; Bilgen I; Memiş A
    Fertil Steril; 2001 Sep; 76(3):445-50. PubMed ID: 11532462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
    Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users.
    Ellingjord-Dale M; Lee E; Couto E; Ozhand A; Qureshi S; Hofvind S; Van Den Berg DJ; Akslen LA; Grotmol T; Ursin G
    Breast Cancer Res; 2012 Oct; 14(5):R135. PubMed ID: 23095343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
    Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric Mammographic Density, Age-Related Decline, and Breast Cancer Risk Factors in a National Breast Cancer Screening Program.
    Hjerkind KV; Ellingjord-Dale M; Johansson ALV; Aase HS; Hoff SR; Hofvind S; Fagerheim S; Dos-Santos-Silva I; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1065-1074. PubMed ID: 29925631
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum prolactin levels are positively associated with mammographic density in postmenopausal women.
    Greendale GA; Huang MH; Ursin G; Ingles S; Stanczyk F; Crandall C; Laughlin GA; Barrett-Connor E; Karlamangla A
    Breast Cancer Res Treat; 2007 Nov; 105(3):337-46. PubMed ID: 17260098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
    McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
    AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells-A prospective randomized trial.
    Hirschberg AL; Tani E; Brismar K; Lundström E
    Maturitas; 2019 Aug; 126():18-24. PubMed ID: 31239112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
    Kerlikowske K; Cook AJ; Buist DS; Cummings SR; Vachon C; Vacek P; Miglioretti DL
    J Clin Oncol; 2010 Aug; 28(24):3830-7. PubMed ID: 20644098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
    Aiello EJ; Buist DS; White E
    Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women.
    Aiello EJ; Tworoger SS; Yasui Y; Stanczyk FZ; Potter J; Ulrich CM; Irwin M; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1411-7. PubMed ID: 15941949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
    Laya MB; Larson EB; Taplin SH; White E
    J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
    Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
    Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammographic changes related to different types of hormonal therapies.
    Pongsatha S; Muttarak M; Chaovisitseree S; Luewan S; Panpanit A
    J Med Assoc Thai; 2006 Feb; 89(2):123-9. PubMed ID: 16578996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.
    van Duijnhoven FJ; Peeters PH; Warren RM; Bingham SA; Uitterlinden AG; van Noord PA; Monninkhof EM; Grobbee DE; van Gils CH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):462-7. PubMed ID: 16537702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
    J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
    Nahas-Neto J; Luca LA; Griva BL; Morceli J; Nahas EA; Moriguchi SM; Uemura G; Traiman P
    Maturitas; 2006 Jan; 53(1):97-106. PubMed ID: 15941630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.